NRC
NRC HealthBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-22
Current thesis
Primary-source evidence improved after earnings: record TRCV, resumed year-over-year revenue growth, healthy Q1 cash generation, and management commentary around stronger sales and retention all support a modestly positive thesis [#8-K-2026-04-28-Earnings] [#PR-2026-03-04].
Posture
Constructive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-07-28.
What can break
Low coverage and no visible analyst-target dataset reduce external validation and make post-earnings price discovery noisier.
Momentum
77
Value
55
Sentiment
43
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $17.50 · Bull $20.00 · Bear $14.50
Earnings
2026-07-28
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $23.00
Why
Momentum77 · Δ7d +11.9
Value55 · Δ7d +0.0
Sentiment43 · Δ7d +1.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
77
26% active weight
Current posture
7d trendFlat
Δ7d
+11.9
Δ21d
+7.7
Value
55
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.2
Sentiment
43
34% active weight
Current posture
7d trendImproving
Δ7d
+1.5
Δ21d
-1.6
Why this grade
Composite grade B. Momentum 77.0 / Value 55.1 / Sentiment 42.7
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$484.09M
Beta
0.50
Shares Out
22.54M
P/E (TTM)
26.3
P/S (TTM)
3.06
P/FCF (TTM)
812.90
Rev YoY
+3.7%
EPS YoY
-44.0%
Gross Margin
+55.9%
Op Margin
+19.8%
Net Debt
$75.65M
Current Ratio
0.52
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology